Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,822 | -3,464 | N/A | N/A |
| Depreciation Amortization | 74 | 206 | N/A | N/A |
| Accounts payable and accrued liabilities | 980 | -40 | N/A | N/A |
| Other Working Capital | 887 | 159 | N/A | N/A |
| Other Operating Activity | -825 | 255 | 0 | 0 |
| Operating Cash Flow | $-3,706 | $-2,884 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2 | N/A | N/A | N/A |
| Investing Cash Flow | $-2 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 61 | 1,150 | N/A | N/A |
| Debt Repayment | -65 | -28 | N/A | N/A |
| Common Stock Issued | N/A | 4,980 | N/A | N/A |
| Other Financing Activity | 0 | -10 | 0 | 0 |
| Financing Cash Flow | $-4 | $6,092 | $N/A | $N/A |
| Beginning Cash Position | 3,821 | 613 | N/A | N/A |
| End Cash Position | 109 | 3,821 | N/A | N/A |
| Net Cash Flow | $-3,712 | $3,208 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,706 | -2,884 | N/A | N/A |
| Capital Expenditure | -2 | N/A | N/A | N/A |
| Free Cash Flow | -3,708 | -2,884 | 0 | 0 |